This page summarizes information about the clinical trials that support investigation of both approved and experimental medicines. This information includes information about the interventions and their sponsoring organizations. Note that these data are derived from ClinicalTrials.gov, with information corrected and disambiguated to convey more accurate detail about these trials. Phase 4 trials are currently excluded on this page by default, as this data will be analyzed separately at a later date.
Trials with Experimental APIs
Top 5 (by most trials)
gluten (34) trifolium pratense (32) blueberry allergenic extract (19) whole wheat allergenic extract (8) viaskin peanut (7)Trials with Approved APIs
Top 5 (by most trials)
house dust mite allergen (75) timothy grass pollen allergen extract (54) birch allergen (38) peanut allergen (30) short ragweed pollen allergen (29)Trials with Unapproved APIs
Top 5 (by most trials)
NoneAPIs in Phase 1
Top 5 (by most trials)
house dust mite allergen (17) peanut allergen (15) cat epidermis allergen (12) short ragweed pollen allergen (10) timothy grass pollen allergen extract (8)APIs in Phase 2
Top 5 (by most trials)
timothy grass pollen allergen extract (40) house dust mite allergen (40) birch allergen (25) trifolium pratense (20) short ragweed pollen allergen (17)APIs in Phase 3
Top 5 (by most trials)
timothy grass pollen allergen extract (25) house dust mite allergen (23) birch allergen (13) trifolium pratense (13) short ragweed pollen allergen (5)Phase 2 Sponsors
Top 5 (by most trials)
Circassia Limited (20) ALK-Abello, S.A. (16) Leti Pharma GmbH (15) Adiga Life Sciences, Inc. (14) National Institute of Allergy and Infectious Diseases (NIAID) (13)Phase 3 Sponsors
Top 5 (by most trials)
ALK-Abello, S.A. (20) Allergopharma GmbH & Co. KG (12) Stallergenes (10) DBV Technologies (6) Inmunotek S.L. (6)